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1 |  INTRODUCTION
The neutrophilic dermatoses are uncommon in pediatric pa-
tients and are characterized by infiltration of neutrophils in 
the skin and occasionally in extracutaneous tissue.1 In neu-
trophilic eccrine hidradenitis (NEH), the neutrophilic infil-
trate has a special predilection for the eccrine glands.1 Due 
to association with fever and similar clinical appearance 
to cellulitis, the diagnosis of NEH requires a skin biopsy.2 
Additionally, infectious workup should be performed to rule 
out infectious etiology because the treatment would be differ-
ent.2 Sweet Syndrome, another type of neutrophilic dermato-
sis, is classically associated with extracutaneous involvement 
including the central nervous system, bone marrow, heart, 
lung, muscles, and spleen.3 NEH, however, is not typically 
associated with extracutaneous disease. Resolution of skin le-
sions is usually spontaneous; however, recovery occurs much 
earlier if steroids or NSAIDs are given.
2 |  CASE DESCRIPTION
A 16‐year‐old male with a history of synovial sarcoma of the 
right posteromedial knee undergoing induction chemotherapy 
presented with a one‐day history of left upper quadrant 
abdominal pain and fever. Pain was not associated with eat-
ing, stooling, nausea, or vomiting and was only minimally re-
lieved with oxycodone 5 mg. Physical examination revealed 
left upper quadrant tenderness, however, no guarding or ri-
gidity. There were no other localizing signs of infection. The 
patient had his port accessed for labs recently, placing him 
at risk for bacteremia. Initial laboratory workup revealed a 
white blood cell count of 21 500, C‐reactive protein (CRP) of 
3.01, and a normal lactate. Blood cultures and urine culture 
were also obtained prior to antibiotic initiation. He was hos-
pitalized and started on cefepime. Abdominal tenderness was 
attributed to constipation due to recent history of hard stools 
and was treated with a bowel regimen.
After three days of therapy, fever and abdominal pain per-
sisted with a rising white cell count to 38 800 and CRP of 
29.86. Blood cultures (including fungal culture) and urine 
culture showed no growth. Antibiotic coverage was expanded 
to include vancomycin. Abdominal CT was performed due 
to concern for an abscess, which revealed moderate retained 
fecal material, asymmetric thickening and edema of the left 
lateral abdominal wall musculature, reflecting myositis, and 
mild splenomegaly, however, no intra‐abdominal abscess. 
He also developed 2‐3 cm, tender, blanching erythematous 
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patches on his abdomen and upper right arm (Figure 1). 
Workup was initiated for septic emboli and was negative. 
New lesions continued to erupt, with expanding size of pre-
vious lesions. This included a large plaque on the left abdo-
men/flank where his previous abdominal pain was located. 
Further history revealed that a similar lesion occurred on 
his left chest wall after his second cycle of chemotherapy 
during an admission for febrile illness and resolved after dis-
charge (Figure 2). Chart review revealed that the patient had 
received pegfilgrastim twelve days prior to the onset of his 
current skin lesions and within eleven days of his initial erup-
tion (Table 1). He received doxorubicin and ifosfamide in his 
first two cycles of chemotherapy and ifosfamide alone during 
his third cycle of chemotherapy (Table 1). During his hos-
pitalization, he received cefepime for a total of six days and 
vancomycin for a total of three days. Despite broad‐spectrum 
antibiotics, he remained intermittently febrile and laboratory 
workup continued to demonstrate an upward trending CRP. 
Dermatology was consulted to perform a skin biopsy of his 
lesions. Per their recommendations, he was started on pred-
nisone therapy to treat presumed acute febrile neutrophilic 
dermatosis and antibiotics were discontinued. Lesions started 
to rapidly resolve within 24‐48 hours of therapy initiation. 
Additionally, CRP started to improve within 48 hours of 
starting steroids. Dermatopathology revealed sparse neutro-
philic infiltrate focally involving the eccrine unit, suggestive 
of NEH (Figure 3). Culture from the skin biopsy specimen 
showed no growth of aerobes, fungi, or Mycobacterium tu-
berculosis. He was discharged home after his clinical condi-
tion improved on a two‐week course of oral steroids. Because 
pegfilgrastim was determined as the likely causative agent, it 
was discontinued. He subsequently received four more cycles 
of ifosfamide and doxorubicin without pegfilgrastim and did 
F I G U R E  1  Left sided erythematous abdominal plaque
F I G U R E  2  Erythematous plaques on right chest and lower 
abdomen which developed during previous hospitalization 11 d after 
G‐CSF administration
T A B L E  1  Patient's chemotherapy schedule and association with 
development of NEH
Date
Administered drugs
Doxorubicin Ifosfamide Pegfilgrastim
1/17/2017 X X
1/18/2017 X X
1/19/2017 X
1/21/2017 X
2/6/2017 X X
2/7/2017 X X
2/8/2017 X X
2/10/2017
2/21/2017 a
2/25/2017 X
2/26/2017 X
2/27/2017 X
3/1/2017 X
3/13/2017 b
3/24/2017 X
3/25/2017 X
3/26/2017 X
5/8/2017 X X
5/9/2017 X X
5/10/2017 X
5/31/2017 X X
6/1/2017 X X
6/2/2017 X
6/21/2017 X
6/22/2017 X
aAdmission for fever with similar, but less intense rash which resolved likely 
secondary to steroids given for nausea. 
bDevelopment of skin lesions seen in NEH described in case report. 
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not have recurrence of his skin lesions (Table 1). In retro-
spect, his initial eruption was also likely due to NEH given 
lack of improvement with antibiotics but improvement with 
steroids which were coincidentally given for nausea.
3 |  DISCUSSION
Neutrophilic eccrine hidradenitis is a rare neutrophilic 
dermatosis characterized by the development of tender, 
edematous, erythematous papules and plaques.1 Histologic 
examination shows neutrophilic infiltration of the eccrine 
unit and necrosis of the eccrine coils and glands.2 It has been 
associated with malignancies such as acute myelogenous 
leukemia (AML), Wilms’ tumor, testicular carcinoma, os-
teosarcoma, Hodgkin’s disease, and Non‐Hodgkin’s lym-
phoma.4 Occurrence in the setting of synovial sarcoma, to 
our knowledge, has not previously been described. It has also 
been associated with chemotherapeutic agents including cyt-
arabine, anthracyclines, bleomycin, cisplatin, and methotrex-
ate.3 Seventy percent of chemotherapy‐related NEH occur 
after the first course of chemotherapy.3 Our patient did not 
develop NEH until after his second cycle of doxorubicin (an 
anthracycline) and moreover, received anthracyclines later 
in his course without development of NEH, making this less 
likely the cause of his NEH. Association with ifosfamide has 
not been previously described. Infections (HIV, Nocardia, 
Serratia, and Staphylococcus), Granulocyte colony‐stimu-
lating factor (G‐CSF), systemic lupus erythematosus, and 
Behcet disease are other associated etiologies.1,5,6 In our pa-
tient’s case, infection was unlikely the cause of his NEH as 
his blood cultures remained negative during his course and 
CRP continued to climb despite broad‐spectrum antibiotics, 
only improving after steroid administration.
3.1 | Pathophysiology
Neutrophilic eccrine hidradenitis secondary to chemo-
therapy has been thought to represent a reaction to toxic 
drugs excreted in sweat.5 It has been suggested that G‐
CSF induced NEH occurs secondary to enhanced chem-
otaxis of neutrophils and stimulation of neutrophilic 
progenitors.5 In healthy children with NEH, destruction 
of immature eccrine glands by high temperatures with re-
sultant inflammatory infiltrate has been proposed as an 
additional pathogenetic mechanism.7 Another hypothesis 
is that NEH may be a hypersensitivity reaction within the 
spectrum of other neutrophilic dermatoses such as Sweet 
syndrome.8
3.2 | Clinical presentation
Patients classically present with tender, erythematous and 
edematous papules and plaques and rarely, with purpuric le-
sions.5 Sites of involvement include the upper trunk, upper 
limbs, face (especially the periorbital area), palms, and 
soles.1,2 The axillae and inguinal folds are classically spared. 
Many patients also present with a fever which may precede 
the onset of the lesions.4 Extracutaneous manifestations in-
cluding myositis and splenomegaly (as seen in our patient) 
have been previously reported in Sweet syndrome, however, 
not in NEH.3,9
3.3 | Diagnosis
Neutrophilic eccrine hidradenitis can mimic cellulitis, and 
therefore, infection should be ruled out. The diagnosis is 
histologic, requiring a punch biopsy.2 The primary histo-
logic feature is neutrophilic infiltrate in and around the 
eccrine glands.1 In neutropenic patients, the degree of infil-
trate may be minimal. Therefore, in such patients, degenera-
tive changes of the eccrine glands may be helpful in making 
the diagnosis.1 If a hematologic malignancy is suspected, 
a complete blood count should be obtained. In addition, 
medication intake should be reviewed for potential causa-
tive agents.1
3.4 | Treatment
Lesions typically resolve spontaneously within a few days 
or weeks of discontinuation of causative medications.5 Oral 
corticosteroids, colchicine, anti‐pyretics, and other non‐ste-
roidal anti‐inflammatory drugs have been found to accelerate 
resolution.1,3,10
F I G U R E  3  Edema and rare neutrophils in the adventitial dermis 
around the secretory segment of the eccrine apparatus. Neutrophils 
noted with green arrows (H/E, X400 original magnification. Skin 
biopsy from anterior abdominal wall lesion)
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4 |  CONCLUSIONS
Neutrophilic eccrine hidradenitis is an acute febrile neutro-
philic dermatosis associated with malignancies, chemother-
apeutic agents, infections, and G‐CSF.1 Only a few cases of 
NEH have been previously reported in the pediatric popu-
lation. NEH may clinically appear similar to infection and 
therefore must be distinguished by blood cultures and skin 
biopsy to guide appropriate therapy.2 Extracutaneous in-
volvement, although seen in Sweet Syndrome, has not been 
previously reported in NEH.3,9 Our patient with synovial 
sarcoma was a unique case of skin biopsy proven NEH who 
also developed extracutaneous involvement in the form of 
myositis and splenomegaly, likely secondary to G‐CSF.
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